Title

Discovery of a Stress-Activated Protein Kinase Inhibitor for Lymphatic Filariasis

Document Type

Article

Publication Date

3-8-2018

Abstract

Lymphatic filariasis infects over 120 million people worldwide and can lead to significant disfigurement and disease. Resistance is emerging with current treatments, and these therapies have dose limiting adverse events; consequently new targets are needed. One approach to achieve this goal is inhibition of parasitic protein kinases involved in circumventing host defense mechanisms. This report describes structure-activity relationships leading to the identification of a potent, orally bioavailable stress activated protein kinase inhibitor that may be used to investigate this hypothesis.

DOI

10.1021/acsmedchemlett.7b00477

This document is currently not available here.

Share

COinS